Socioeconomic inequalities in the incidence and prevalence of type 2 diabetes mellitus in Europe  by Espelt, Albert et al.
OS
o
A
R
a
b
c
d
e
f
g
h
A
R
A
A
K
S
D
I
P
E
P
F
D
I
P
E
0
hGac Sanit. 2013;27(6):494–501
riginal  article
ocioeconomic  inequalities  in  the  incidence  and  prevalence
f  type  2  diabetes  mellitus  in  Europe
lbert  Espelta,b,c,d,∗, Carme  Borrella,b,c, Laia  Palènciaa,b,c, Alberto  Godaye, Teresa  Spadeaf,
oberto  Gnavif,  Laia  Font-Riberag,b,  Anton  E.  Kunsth
Agència de Salut Pública de Barcelona, Barcelona, Spain
CIBER de Epidemiología y Salud Pública (CIBERESP), Spain
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain
Departament de Psicobiologia i Metodologia de les Ciències de la Salut, Universitat Autònoma de Barcelona, Bellaterra (Barcelona), Spain
Endocrinology and Nutrition Service, Hospital del Mar, Universidad Autónoma de Barcelona, Barcelona, Spain
Epidemiology Unit, Local Health Authority TO3 of Piedmont Region, Italy
Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain
Department of Public Health, Academic Medical Centre (AMC), University of Amsterdam, Amsterdam, The Netherlands
a  r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 10 December 2012
ccepted 18 March 2013
vailable online 3 May  2013
eywords:
ocioeconomic factors
iabetes mellitus type 2
ncidence
revalence
urope
a  b  s  t  r  a  c  t
Objective:  The  aim  of this  study  was  to analyze  socioeconomic  position  (SEP)  inequalities  in the  prevalence
and  incidence  of  type  2 diabetes  mellitus  (T2DM)  in people  aged  50  years  and  over  in Europe  and  to
describe  the contribution  of  body  mass  index  (BMI)  and  other  possible  mediators.
Methods:  This  was  a cross-sectional  and  longitudinal  study  including  men  and  women  ≥50  years  old  in
11  European  countries  in  2004  and  2006  (n =  21,323).  The  prevalence  and  cumulative  incidence  of  T2DM
were  calculated  with  self-reported  T2DM  or when  the  individual  took drugs  for diabetes.  Prevalence  ratio
(PR) and  relative  risk  (RR)  of  prevalent  and  incident  T2DM  were  calculated  according  to  educational  level
and adjusted  by BMI  and  other  possible  mediators.
Results:  The  age-adjusted  and  country-adjusted  prevalence  of  T2DM  in 2004 was 10.2%  in  men  and
8.5%  in  women.  Compared  to those  with  higher  education,  men  and  women  with  lower  education  had
a  PR  [95% CI]  of  T2DM  of  1.29  [1.12–1.50]  and  1.61  [1.39–1.86],  respectively.  SEP-related  inequalities
in incidence  (RR  [95%CI])  were  1.88  [1.35–2.62]  in  women  and  1.04  [0.78–1.40]  in men.  Adjusting  for
potential  mediators  reduced  inequalities  in the  prevalence  and  incidence  of T2DM  among  women  by
26.2%  and  21.6%,  respectively,  and  inequalities  in prevalence  among  men  by  44.8%.
Conclusions:  We  observed  signiﬁcant  inequalities  in  the prevalence  and  incidence  (women  only)  of  T2DM
as  a  function  of socioeconomic  position.  These  inequalities  were  mediated  by BMI.
© 2012  SESPAS.  Published  by Elsevier  España,  S.L.  All rights  reserved.
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Objetivo:  Analizar  las  desigualdades  por  posición  socioeconómica  en  la  prevalencia  y la  incidencia  de
diabetes mellitus  de  tipo 2 (DM2)  en  las personas  de  50 o más  an˜os de  edad  en  Europa,  y  describir  la
contribución  del  índice  de  masa  corporal  (IMC)  y la  de  otros  posibles  mediadores.
Métodos:  Estudio  de  disen˜o  transversal  y longitudinal  que  incluye  personas  de  50 o más  an˜os de  edad  de
11  países  de  Europa,  entre  2004  y 2006  (n =  21.323).  Se  calculó  la prevalencia  y la  incidencia  acumulada  de
DM2  a partir  del  autorreporte  de  DM2  o de  si la  persona  consumía  fármacos  para  la diabetes.  Se estimaron
riesgos  relativos  (RR)  de  incidencia  y razones  de  prevalencia  (RP) de  DM2  según  el  nivel  educativo,  y se
ajustaron  por  el  IMC y otros  posibles  mediadores.
Resultados:  La  prevalencia  de  DM2  ajustada  por edad  y  país  en  2004  era  del 10,2%  en  los  hombres  y  del
8,5% en las  mujeres.  Comparado  con  las  personas  con un  nivel  de  estudios  más  alto,  los  hombres  y las
mujeres  con menor  nivel  de  estudios  tenían  una  RP  (IC95%)  de DM2  de  1,29  (1,12–1,50)  y 1,61 (1,39–1,86),
respectivamente.  Las  desigual
1,88  (1,35–2,62)  en  las  mujer
mediadores,  las  desigualdades
26,2% y  un  21,6%,  respectivam
Conclusiones:  Se  observan  des
en función  de  la posición  socio
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es  y de  1,04 (0,78–1,40)  en  los  hombres.  Ajustando  por  los  potenciales
 en  la  prevalencia  y  la  incidencia  de  DM2  se redujeron  en las mujeres  un
ente,  y las  desigualdades  en  la  prevalencia  en  los  hombres  un  44,8%.
igualdades  en  la  prevalencia  y  la  incidencia  (sólo  en  las  mujeres)  de  DM2
económica.  Estas  desigualdades  estaban  mediadas  por el  IMC.
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Diabetes is a growing global health problem, and an estimated
.4% of the global population will have diabetes by 2030.1 The
ncreased prevalence observed in recent years is mainly attributed
ot only to an increase in the incidence in type 2 diabetes mel-
itus (T2DM), but it could also be due to declining mortality
mong T2DM patients2–4 in some countries. This increased inci-
ence is likely due to the increased prevalence of its main risk
actors, such as obesity and sedentarism,1–6 while declining mor-
ality among T2DM patients may  be explained by improvements in
reatment.3,4 Moreover, disease monitoring and improved access
o health services play an important role in preventing diabetes-
elated complications.7
Inequalities in the incidence, prevalence and mortality of T2DM
s a function of socioeconomic position (SEP) have been described
n some populations.7–12 People with disadvantaged SEP (low
ncome, deprived occupational social class and/or low educational
evel) experience higher rates of incidence and prevalence and are
ore likely to die from T2DM than those with high SEP.7 Some
tudies have suggested that the presence of SEP-related inequal-
ties in T2DM are mediated13 by the unequal distribution of risk
actors for T2DM between levels of SEP,9,14 and indeed obesity,
hysical inactivity, and unhealthy diet are most prevalent among
hose with the lowest SEP.15 For example, obesity has been reported
o account for 26% and 36% of the variance in the prevalence of
2DM in middle-aged European men  and women, respectively.16
owever, there has been some debate regarding the existence of
esidual SEP-related inequalities in the incidence and prevalence
f T2DM after adjusting for these traditional risk factors.9–12,14 It
s also necessary to consider that these factors may  in part be the
esult of the conditions in which people are born, grow, live, work
nd age, conditions that are shaped by the distribution of money,
ower and resources at global, national and local levels.
To date, no Europe-wide follow-up studies have been reported
hat analyze social inequalities in both incidence and prevalence of
2DM and the contribution of their risk factors to these inequal-
ties. Studying inequalities in the incidence and prevalence of
iabetes across Europe may  help to identify general patterns that
re independent of the characteristics of speciﬁc countries. Further-
ore, assessing the role of potential mediators of the relationship
etween SEP and T2DM incidence or prevalence may  aid the design
f speciﬁc strategies aimed at reducing these inequalities. The aim
f this study was to analyze SEP-related inequalities in the preva-
ence and incidence of T2DM in people aged 50 years and over in
urope between 2004 and 2006 and to describe the contribution of
ody mass index (BMI) and other possible mediators of SEP-related
nequalities in T2DM.
ethods
A cross-sectional and longitudinal analysis of a group of indi-
iduals was performed on the basis of the results of two phases
f the Survey of Health, Ageing and Retirement in Europe (SHARE)
n 2004 and 2006. SHARE is a multidisciplinary and trans-national
uropean study that has collected information on health, SEP and
amily networks of individuals aged ≥50 years. In this study we
ncluded men  and women aged ≥50 years who  resided in 11
uropean countries (Austria, Belgium, Denmark, France, Germany,
reece, Italy, Spain, Sweden, Switzerland and The Netherlands).
hese are the countries that participated in 2004 and had a fol-
ow up in the second wave (In 2004, the individual response rate
anged from 73.7% in Spain to 93% in Denmark). All countries
ttempted proper probability sampling. For more information
bout SHARE-project it is possible to consult its web page,013;27(6):494–501 495
where there is a lot of additional methodological information
(www.share-project.org). The ﬁnal sample size consisted of indi-
viduals who were part of the main sample of SHARE-project, aged
50 years or more.
The prevalence of T2DM was calculated among individuals
enrolled in the ﬁrst phase of the survey in 2004 (n = 21,323). T2DM
status was  self-reported, using the same survey questions in 2004
and 2006: (1) “Has a doctor ever told you that you had any of
the conditions on this card? Diabetes or high blood sugar”, or (2)
“Do you currently take drugs at least once a week for problems
mentioned on this card? Drugs for diabetes”. People who reported
diagnosis of diabetes before 20 years of age (1.3%) were considered
as they did not have T2DM since they are more likely to be affected
by type 1 diabetes. Using data collected during the second phase of
the survey in 2006, the cumulative Incidence of T2DM was calcu-
lated on the basis of individuals who did not have diabetes in 2004
(n = 12,811; 39.9% were lost to follow-up).
Information on educational level (as a measure of SEP) was  col-
lected in the ﬁrst phase of the survey and classiﬁed according to
the International Standard Classiﬁcation of Education (ISCED-11)
(www.unesco.org). Some categories of this classiﬁcation were col-
lapsed because of the low numbers of individuals in some groups.
The ﬁnal variable was made up of the following categories: ISCED <3
(lower secondary education or less) or ISCED ≥3 (upper secondary
education or more).
The following variables were collected as potential mediators
of the association between education and T2DM: BMI  was cal-
culated using self-reported weight and height, and was analyzed
as both a continuous variable and a 4-level categorical variable:
(1) underweight (<18.5 kg/m2); (2) normal (18.5–24.9 kg/m2); (3)
overweight (25–29.9 kg/m2); and (4) obese (≥30 kg/m2). Smoking
status was classiﬁed as: (1) currently a smoker, (2) never a smoker,
and (3) a former smoker. An individual’s alcohol consumption was
considered excessive if he reported drinking more than two  glasses
of beer, cider, wine, spirits or cocktails on ﬁve or more days a week.
Physical inactivity was  deﬁned as never or almost never engaging in
moderate or vigorous physical activity such as sports, heavy house-
work, or a job that involves physical labor. We note that although
we have considered the risk factors mentioned above as potential
mediators of the link between SEP and T2DM risk, some may  not
be part of the chain of causality between SEP and T2DM and there-
fore might be better considered as potential confounders.13 Age
and country were treated as potential confounding variables.
Data analysis
All analyses were stratiﬁed by sex. Crude and age-adjusted (by
the direct method, using the entire sample as the standard for each
phase) and country-adjusted (to ensure that all the countries con-
tribute in the same magnitude) prevalence and incidence of T2DM
were calculated for each educational level. In order to study the
association between educational level and the prevalence and inci-
dence of T2DM, a Poisson regression model with robust variance
was used to calculate age-adjusted and country-adjusted preva-
lence ratio (PR) and relative risk (RR), respectively. To explore
the effects of BMI  (as a continuous quadratic variable), smoking,
physical activity and alcohol consumption, we  had ﬁtted addi-
tional models, introducing each variable individually and then all
variables simultaneously. The contribution of each independent
variable in the relationship between prevalence or cumulative inci-
dence of T2DM and educational level was quantiﬁed by calculating
the percentage change in PR or RR of each model before and after
introducing each independent variable. Finally, among the individ-
uals without diabetes in phase I, we  compared the characteristics
of those who were available for follow-up to those who were not.
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Table 1
Description of study populations.
Phase I (2004) Phase II (2004–2006)
Men  Women  Men  Women
n  (%) n (%) n (%) n (%)
Age (years)
50–59 3943 (39.9) 3944 (34.4) 2445 (41.7) 2571 (37.0)
60–69 3066 (31.1) 3253 (28.4) 1867 (31.8) 2066 (29.8)
70–79 2027 (20.5) 2666 (23.3) 1143 (19.5) 1543 (22.2)
≥80  838 (8.5) 1586 (13.9) 412 (7.0) 764 (11.0)
Educational level
Lower secondary or less 4425 (44.8) 6515 (56.9) 2543 (43.3) 3783 (54.5)
Upper secondary or more 5450 (55.2) 4933 (43.1) 3324 (56.7) 3160 (45.5)
BMI
Underweight 53 (0.5) 242 (2.1) 23 (0.4) 132 (1.9)
Normal weight 3377 (34.3) 5097 (44.6) 2059 (35.1) 3190 (45.9)
Overweight 4846 (49.2) 4070 (35.6) 2895 (49.3) 2462 (35.5)
Obese 1582 (16.0) 2016 (17.7) 889 (15.2) 1159 (16.7)
Smoking
Current 2403 (24.4) 1820 (15.9) 1411 (24.0) 1130 (16.3)
Never 3456 (35.1) 7609 (66.6) 2100 (35.8) 4577 (65.9)
Former 3996 (40.5) 1999 (17.5) 2356 (40.2) 1236 (17.8)
Alcohol consumption
No 7682 (78.0) 10,690 (93.5) 4541 (77.4) 6475 (93.3)
Yes  2171 (22.0) 737 (6.5) 1326 (22.6) 468 (6.7)
Physical inactivity
No 9067 (92.0) 9940 (87.0) 5541 (94.4) 6263 (90.2)
Yes  786 (8.0) 1488 (13.0) 326 (5.6) 680 (9.8)
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Among the participants of phase I, 65% of men  and 53% of women
ere overweight or obese and 92% of men  and 87% of women per-
ormed some type of physical activity (Table 1). Fifty-ﬁve percent of
en  and 43% of women had upper secondary education or higher.
he individuals included in the second phase of the study had sim-
lar prevalences of these risk factors, but were generally younger
nd more physically active than those included in the ﬁrst phase
both with p < 0.01).
Prevalence of T2DM in men  ranges from 8.4% [95% CI: 6.3–10.4]
n Denmark to 15.3% [95% CI: 12.5–18.1] in Spain, while in women
anges from 4.5% [95% CI: 2.6–6.5] in Switzerland to 14.2% [95% CI:
1.8–16.6] in Spain. The two-year cumulative incidence of T2DM
n men  goes from 2.2% [95% CI: 0.8–3.7] in Denmark to 7.1% [95%
I: 4.9–9.4] in The Netherlands, and in women goes from 1.9%
95% CI: 0.7–3.1] in Denmark to 7.8% [95% CI: 5.1–10.4] in Spain
0%
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10%
12%
14%
16%
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20%
Austria Germany Sweden Netherlands Spain Ita
Prevalence (men) Prevalence (women ) 
Figure 1. Prevalence (year 2004) and cumulative incidence (200) 5867 (100.0) 6944 (100.0)
(Fig. 1). The age- and country-adjusted prevalence [95% CI] of T2DM
in the ﬁrst phase was 10.2% [95% CI: 9.5–10.8] in men and 8.5%
[95% CI: 7.9–9.1] in women. The age- and country-adjusted cumu-
lative incidence of T2DM in the period 2004–2006 was 3.8% [95% CI:
3.3–4.3] in men  and 3.4% [95% CI: 2.9–3.9] in women (not shown in
the tables). BMI  was the strongest predictor of the prevalence (PR
among obese versus normal weight 2.92 [95% CI: 2.46–3.47] in men
and 3.67 [95% CI: 3.12–4.31] in women) and incidence (RR among
obese versus normal weight 3.34 [95% CI: 2.33–4.80] in men  and
4.07 [95% CI: 2.85–5.80] in women) of T2DM (Table 2).
In relation to SEP-related inequalities (Fig. 2 and Table 3),
women with a lower secondary level education or less had a higher
prevalence of T2DM (PR = 1.61 [95% CI: 1.39–1.86]) in the ﬁrst phase
of the survey and a higher incidence (RR = 1.88 [95% CI: 1.35–2.62])
during follow-up, compared to women  with a upper secondary or
more. A similar pattern of SEP-related inequality in the prevalence
(PR = 1.29 [95% CI: 1.12–1.50]), but not the incidence (RR = 1.04 [95%
ly France Denmark Greece Switzerland Belgium
Incidence (men) Incidence (women )
04–2006) of T2DM aged 50 years by gender and country.
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Table  2
Age- and country-adjusted prevalence ratio and relative risk of T2DM in Europeans aged 50 years and over 2004–2006.
Men  Women
Prevalence Incidencea Prevalence Incidencea
PR (95% CI) RR (95% CI) PR (95% CI) RR (95% CI)
Age (years)
50–59 1 1 1 1
60–69 1.72 (1.46–2.03) 1.84 (1.33–2.55) 1.78 (1.50–2.10) 1.47 (1.05–2.05)
70–79  2.10 (1.78–2.49) 1.79 (1.25–2.56) 2.32 (1.96–2.75) 2.01 (1.42–2.83)
≥80  1.71 (1.34–2.17) 1.98 (1.21–3.24) 2.54 (2.08–3.09) 2.01 (1.25–3.25)
Educational level
Upper secondary or more 1 1 1 1
Lower  secondary or less 1.29 (1.12–1.50) 1.04 (0.78–1.40) 1.61 (1.39–1.86) 1.88 (1.35–2.62)
BMI
Normal  weight 1 1 1 1
Underweight 1.36 (0.59–3.16) – 0.89 (0.46–1.70) 2.04 (0.75–5.57)
Overweight 1.60 (1.37–1.88) 1.73 (1.24–2.41) 1.95 (1.65–2.29) 2.08 (1.49–2.90)
Obese  2.92 (2.46–3.47) 3.34 (2.33–4.80) 3.67 (3.12–4.31) 4.07 (2.85–5.80)
Smoking
Never  1 1 1 1
Current  1.20 (1.01–1.43) 1.53 (1.08–2.16) 0.78 (0.63, 0.96) 1.25 (0.85–1.84)
Former  1.34 (1.16–1.55) 1.41 (1.04–1.91) 0.98 (0.82, 1.16) 0.72 (0.49–1.08)
Alcohol  consumption
No 1 1 1 1
Yes  0.85 (0.73–1.00) 1.08 (0.79–1.47) 0.49 (0.34, 0.71) 0.78 (0.44–1.38)
Physical  inactivity
No 1 1 1 1
Yes  1.71 (1.41–2.06) 1.86 (1.20–2.88) 1.43 (1.21–1.68) 1.38 (0.93–2.03)
P ass in
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oR: prevalence ratio; RR: relative risk; 95%CI: 95% conﬁdence interval; BMI: body m
a Incidence: new cases of T2DM during 2 years of follow up.
I: 0.78–1.40]) of T2DM was observed among men. The SEP inequal-
ties in incidence and prevalence in each country are shown in Fig. 3.
verall SEP inequalities in the incidence and prevalence of T2DM
ere consistent across countries (Fig. 3). In both prevalence and
ncidence of T2DM, SEP inequalities seemed to be higher in women
han in men. For example, point estimates of SEP inequalities in
2DM incidence among men  were very close to 1 in each country,
hile among women they were higher than 1 in the majority of
ountries. For overall estimations, SEP-related inequalities in the
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igure 2. Age-and country-adjusted prevalence (year 2004) and cumulative incidence (2
ver.dex.
prevalence and incidence of T2DM were signiﬁcantly greater in
women compared to men  (p-value for the interaction between sex
and SEP: 0.017 for prevalence; 0.005 for incidence).
The most important mediator risk factor for SEP-related inequal-
ities in both the prevalence and incidence of T2DM was  BMI,
accounting for 23.0% and 15.9% of the inequality in prevalence and
incidence among women, respectively (Table 3). After adjusting for
all the potential mediators simultaneously, SEP-related inequalities
in the prevalence of T2DM were reduced by 44.8% and 26.2% in men
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004–2006) of T2DM according to educational level in Europeans aged 50 years and
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Table 3
SEP-related inequalities in the prevalence and incidence of T2DM according to educational level and % changea after adjustment for potential mediator variables. Europeans
aged  50 years and over, 2004–2006.
Men  Women
Prevalence Incidenceb Prevalence Incidenceb
PR (95%CI) RR (95%CI) PR (95%CI) RR (95%CI)
Crude model (adjusted for age and country)
Upper secondary or more 1 1 1 1
Lower  secondary or less 1.29 (1.12–1.50) 1.04 (0.78–1.40) 1.61 (1.39–1.86) 1.88 (1.35–2.62)
Adjusted for BMI2
Lower secondary or less 1.20 (1.03–1.39) 0.98 (0.73–1.31) 1.47 (1.27–1.71) 1.74 (1.24–2.43)
%  change −31.0 −150.0 −23.0 −15.9
Adjusted for smoking
Lower secondary or less 1.27 (1.10–1.47) 1.04 (0.78–1.40) 1.59 (1.37, 1.85) 1.89 (1.35–2.64)
%  change −6.9 0.0 −3.3 1.1
Adjusted for alcohol consumption
Lower secondary or less 1.27 (1.10–1.47) 1.06 (0.79–1.42) 1.57 (1.35–1.82) 1.91 (1.37–2.67)
%  change −6.9 50.0 −6.6 3.4
Adjusted for physical inactivity
Lower secondary or less 1.25 (1.08–1.44) 1.04 (0.78–1.39) 1.55 (1.34–1.80) 1.90 (1.36–2.64)
%  change −13.8 0.0 −9.8 2.3
Fully adjusted model
Lower secondary or less 1.16 (1.00–1.34) 0.96 (0.71–1.28) 1.45 (1.25–1.69) 1.69 (1.20–2.37)
%  change −44.8 −200.0 −26.2 −21.6
PR: prevalence ratio; RR: relative risk; 95%CI: 95% conﬁdence interval; BMI: body mass index.
a RRbefore  control−RRafter  control
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b Incidence: new cases of T2DM during 2 years of follow up.
nd women, respectively, while inequalities in incidence (that was
ound statistically signiﬁcant only among women) were reduced
y 21.6% in women. In men, SEP inequalities in incidence of T2DM
ere not found.
iscussion
In this study, which tries to ensure a large and representative
ample of the European population over 50 years of age, we  identi-
ed SEP-related inequalities in the prevalence of T2DM in men  and
omen and in the two-year incidence of T2DM among women. BMI
ppeared as the main mediator variable explaining these inequali-
ies.
imitations
The study was based on health survey data and it is gener-
lly recognized that respondents report only diagnosed T2DM,
hich represents just 30–50% of all cases.17,18 However, educa-
ional level does not seem to be associated with undiagnosed T2DM,
o self-reported diabetes may  not be subject to signiﬁcant reporting
ias, and may  therefore be a valid tool for evaluating SEP-related
nequalities in diabetes prevalence.19
The ﬁrst phase of this study was carried out using a large repre-
entative sample of the European population aged ≥50 years. The
econd phase, however, whose aim was to evaluate the incidence
f T2DM, lasted only 2 years, which may  be too short an interval
o provide sufﬁcient power to detect real SEP-related inequalities.
herefore, it is possible that statistically signiﬁcant SEP-related
nequalities would be evident in both men  and women after a
onger follow-up period. The small sample size has not allowed us
o obtain conclusive results by country and for this reason a pooled
nalysis, taking into account the variability of each country, was
sed for the multivariate analysis. Moreover, we were not able to
ake conclusions for many different social categories separately,
ue to the limited incidence cases in the period 2004–2006.Finally, the proportion of individuals who  were lost to follow-
up was  considerable (39.9%), and we observed some notable
differences in the characteristics of these individuals and compared
to those of the individuals who were retained. Compared to indi-
viduals who  were retained in the second phase of the study, men
and women  who  were lost to follow up were older, less obese, were
less physically active and with lower educational level (see Table I
in Appendix online). In order to evaluate the comparability of each
phase of the study, we analyzed SEP-related inequalities in preva-
lence in the second phase (not shown in any table), and found the
PR to be very similar to that in ﬁrst phase (men: 1.29 and 1.28 [95%
CI: 1.09–1.439] in the ﬁrst and second phase, respectively; women:
1.61 and 1.72 [95% CI: 1.45–2.04] in the ﬁrst and second phases,
respectively). This suggests that losses to follow-up are unlikely
to have caused important biases in our results, although incidence
results should be taken carefully.
SEP-related inequalities in the prevalence and incidence of T2DM
The socioeconomic inequalities in the prevalence of T2DM
observed in our study have been previously described in a represen-
tative sample of the younger European population (30–64 years).20
Our study indicates that this pattern of SEP-related inequalities
persists in later decades in the European population, and sug-
gests a similar tendency for the incidence of T2DM, consistent with
the results of a recent meta-analysis of studies from 6 European
countries.8 On the contrary, we  observed SEP-related inequalities
in the incidence of T2DM among women but not among men. In a
study based on English older population,11 these inequalities were
found in men  and women when household wealth or subjective
social status was used as a SEP indicator. However, these inequal-
ities were not found in men  when educational level was used,11
which highlights the complexity of SEP indicators and the different
aspects that they measure.21 The ﬁnding of SEP-related inequali-
ties in the prevalence of T2DM in both genders, but corresponding
inequalities in incidence only among women  is unexpected, and
we can suggest several explanations. SEP-related inequalities in
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aRelative risk and bprevalence ratio of T2DM comparing less than secondary studies against secondary or
more than secondary studies; there are not sufficient data in Germany to adjust a regression analysis for
men in incidence of T2DM.   
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Figure 3. Age-adjusted SEP-related inequalities in the prevalence and incidence of T2DM according to educational level in Europeans aged 50 years by gender and country,
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he incidence of T2DM may  occur at younger ages in men  than in
omen. In the Whitehall II study, SEP-related inequalities in the
ncidence of T2DM after 10 years of follow up were found among
en  aged 33–55 years but not among women.14 Moreover, SEP-
elated inequalities in total mortality in Europe are stronger among
ounger men  than older men, but do not vary with age among
omen.22 This could affect the incidence of SEP-related inequal-
ties in T2DM, since men  in the lowest SEP have higher risk of both
2DM and mortality (being mortality a competing risk of incidence
f T2DM). At any rate, further studies on SEP-related inequalities in
he incidence of T2DM with longer follow up and among different
ge groups and genders are required.
valuation of variables that may  explain observed inequalities
n incidence and prevalence of T2DMVarious factors that could potentially explain the SEP-related
nequalities in incidence and prevalence of T2DM observed in this
tudy have been discussed previously.7,11,12,23 In agreement withthe majority of previous studies,7,9,24 we found that BMI  was an
important element of this relationship. It should be noted that
detrimental lifestyle choices (smoking, alcohol consumption, phys-
ical inactivity and poor diet), especially among individuals with
low SEP, could be a way to cope with adverse and stressful sit-
uations related to the precariousness of their working and living
conditions. These unhealthy behaviors must be understood in the
context of limited resources and limited access to health care. In
agreement with previous reports,7,11,24,25 the potential mediator
variables analyzed in our study explain only a part of these SEP-
related inequalities. Some part of the remaining variability may
be accounted for misclassiﬁcation biases such as self-reported BMI
or physical activity, or not measuring variables repeatedly over
time.12 In addition, unmeasured factors such as family history of
diabetes,23,26 diet,24 access to health services,27 labor conditions
and other psychosocial factors,14,28 life-course variables10,29 or
other socioeconomic variables may  also be relevant.11 For example,
in a Swedish study characterized by more precise measurements
of potential mediator variables (such as physical activity and BMI)
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nd psychosocial factors, the authors were able to explain all SEP-
elated inequalities in the prevalence of T2DM in women.26
Our study contributes to the ongoing debate on the risk factors
hat mediate the relationship between SEP-related inequalities and
isk of T2DM, indicating that in Europe these inequalities are partly
ut not entirely explained by various intermediate factors, particu-
arly BMI. Since BMI  is a causal mediator of the relationship between
EP and T2DM, strategies to prevent SEP-related inequalities in
besity could partially reduce SEP-related inequalities in T2DM.
n order to reduce these inequalities, obesity prevention strategies
hould focus on contextual conditions that may  have greater impact
n disadvantaged groups.30 To this end, the WHO  has proposed
nterventions to reduce weight gain and the prevalence of obe-
ity among vulnerable groups in the WHO  European region (e.g.,
nterventions in nutrition, physical activity and sedentarism, and
n economic and psychosocial factors), and recommends that these
nterventions be implemented by settings, sectors and actors.31
ender-related differences
As in other studies,7 we found more pronounced SEP-related
nequalities in T2DM among women than men, and this is thought
o be driven by the burden of risk factors, particularly BMI, which
s particularly prevalent among women with lower SEP.32,33 How-
ver, the gender differences in SEP-related inequalities observed
n our study were not entirely explained by BMI  or other factors.
sychosocial factors28,34 and the different roles and power rela-
ionships between men  and women, which were not measured in
ur study, may  partly explain SEP-related inequalities in women.26
otably, countries such as Finland, Sweden, Denmark and Norway
hich have a higher percentage of women in the labor market and
ore redistribute policies than Spain or Italy35 have fewer gender
ifferences in SEP-related inequalities in T2DM.20
onclusions
In this study we observed signiﬁcant SEP-related inequalities
n the prevalence of T2DM in a representative sample of European
en  and women aged 50 years or over. Similar inequalities in the
ncidence of T2DM were observed in women but not men. These
nequalities are partially mediated by BMI  and other factors. Future
tudies should explore structural and psychosocial factors and
ietary behavior in order to understand why SEP-related inequali-
ies in diabetes persist in Europe.
What is known on this topic?
Socioeconomic inequalities (SEP) in the prevalence of
T2DM are present throughout Europe. The magnitude of SEP
Inequalities in incidence of T2DM in Europe population is not
known. There are not conclusive results about the residual SEP-
related inequalities in the incidence and prevalence of T2DM
after adjusting for traditional risk factors.
What does this study add to the literature?
There are SEP-related inequalities in the prevalence of
T2DM in men  and women aged 50 years or more. There are
SEP-related inequalities in the incidence of T2DM in people
aged 50 years or more only among women. BMI appeared
as the main mediator variable explaining the inequalities in
incidence and prevalence of T2DM.
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